Navigation Links
Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
Date:5/15/2008

ease tablets and Itopride Hydrochloride Granules as well as sales of Baobaole chewable tablets, which grew rapidly from the time the product was first launched in the second quarter of fiscal year 2008.

Gross profit in the third quarter ended March 31, 2008 totaled $21.8 million, an increase of 60.7% from $13.5 million in the prior year's period. Gross margin was 77.4%, compared to 71.5% in the prior year's period. The increase of gross profit was due to increased sales of higher profit margin products, better control over raw material purchases and more efficient manufacturing.

Research and development expenses in the third quarter ended March 31, 2008 totaled $1.0 million, up slightly from the prior year's period. These research and development expenses were related primarily to payments to the two research institutes with which the Company has collaborative agreements.

Selling, general and administrative expenses in the third quarter ended March 31, 2008 totaled $12.1 million, up 25.6% from $9.7 million in the prior year's period. The majority of this increase was because of an increase in commissions to sales representatives. Starting January, 2008, the Company increased its sales commissions to provide better incentives to its sales representatives. Administrative expenses related to being a public company also increased in fiscal year 2008.

Operating income in the third quarter ended March 31, 2008 totaled $8.7 million, a 195.8% increase from $2.9 million in the prior year's period, representing operating margin of 30.8%.

Other expenses in the third quarter ended March 31, 2008 totaled $2.0 million, compared to $80,000 in the prior year's period. The significant increase in the Company's other expense was related primarily to a $1.2 million unrealized loss on trading securities, a $0.5 million amortization expense on discounted debt and a $0.2 million loss from discontinued operations.

Net income for the third quarter
'/>"/>

SOURCE Genesis Pharmaceuticals Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Cardiogenesis Reports First Quarter 2008 Results
2. Effect of mutant p53 stability on tumorigenesis and drug design
3. Cardiogenesis Corporation to Report 2008 First Quarter Results on May 15th
4. A stem cell type supposed to be crucial for angiogenesis and cancer growth does not exist?
5. Mitochondria play role in pathogenesis of AD and estrogen-induced neuroprotection
6. Science of Sri Vidya Benefits DNA Genesis, Says Dr. Sunita Rana Agarwal
7. Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs
8. Genesis Pharmaceuticals Changes Auditors
9. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
10. Cardiogenesis Corporation Reports Delay in Earnings Release and Conference Call
11. Cardiogenesis Corporation to Report 2007 Fourth Quarter and Year-End Results on March 4th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... MJNational LLC strengthens its consultant agreement ... Bizcard ™ platform. This exciting new SMS platform creates ... Sales / Services. Now you can reach out ... products, services and ticker symbol through an easy to ... LLC will provide managed support and services to advance ...
(Date:5/6/2015)... Edvance360 LMS-SN , a leader ... the Software & Information Industry Association's (SIIA) 30th ... Postsecondary Learning Management Solution" category. Edvance360 LMS-SN won ... for this award seven years running, continued proof that ... the industry. , "The honor of being a ...
(Date:5/6/2015)... Mass. (PRWEB) May 06, 2015 ... today announced that CTO David Ting will lead a ... the associated data security and user authentication challenges, during ... Fla.). The session will focus on the benefits of ... in which care providers and patients can share information. ...
(Date:5/6/2015)... As Hilo Medical Center progressed ... Model, the hospital looked for new applications that ... processes. The leadership team realized that while many ... patient registration still required patients to apply ink-on-paper ... Stage 7 attestation fast approaching, Hilo looked for ...
(Date:5/6/2015)... On April 27, 2015, Elle Magazine ... ,” compiled quotes about cosmetic surgery from 16 celebrities. ... Iggy Azalea, and Gwyneth Paltrow. For the most part, ... plastic surgery themselves; only a couple of the ... of youth and beauty. (see: goo.gl/wSomih) , “The quotes ...
Breaking Medicine News(10 mins):Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 2Health News:Cannabiz Mobile Inc. Launches the Canna Bizcard ™ Platform to Support to Cannabis Market 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3Health News:Imprivata to Lead Discussion about Patient and Provider Authentication Challenges and the Internet of Things in Healthcare during Citrix Synergy 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Plastic Surgery: Sixteen Celebrities Offer their Opinion about Going Under the Knife 2
... ... in biofeedback and Mediwatch plc team up to offer a range of pelvic floor ... ... manufacturing company, and Thought Technology Ltd., the worldwide leading expert in biofeedback, have entered ...
... SATURDAY, July 3 (HealthDay News) -- One way to ... fireworks celebrations to the experts, a children,s eye specialist ... Adults, and particularly children, should not play with these ... Dr. Daniel Neely, a pediatric ophthalmologist at the Indiana ...
... David Ettenberg, owner of ... and reality don,t always mesh in how "fat camps" (and the overweight teenage campers who attend ... ... bit of fantasy, our lives would be mighty dull and TV producers know that better than ...
... ... ... From self-published author Don Pilcher comes a gripping novel where two adult siblings discover ... lives of twins Frank and Trina, and the danger that follows them. , , ...
... ... complete resource for anyone in need of a mobility solution for their home. Customers will ... ... US Medical Supplies, an online retailer of more than 10,000 medical and mobility products, announced ...
... ... Inc.,s Magnolia Shop Sells Natural and Organic Meat Raised Locally, , ... Seattle, WA (PRWEB) July 2, 2010 ... the company’s total to five, said J’Amy Owens, chief executive officer., , ,Located at ...
Cached Medicine News:Health News:OEM Partnership Between Thought Technology Ltd. and Mediwatch plc 2Health News:OEM Partnership Between Thought Technology Ltd. and Mediwatch plc 3Health News:Leave July 4 Fireworks to the Pros 2Health News:Real Life "Fat Camp" Owner Disagrees With How Such Camps Are Depicted In ABC Family's new show, "Huge" 2Health News:Real Life "Fat Camp" Owner Disagrees With How Such Camps Are Depicted In ABC Family's new show, "Huge" 3Health News:New Book Tells of a Dark Secret that Puts Adult Twins on the Opposite Sides of the Law 2Health News:US Medical Supplies Publishes 2010 Catalog 2Health News:In Time for July 4th Grilling, Bill the Butcher Opens 5th Butcher Shop 2
(Date:5/6/2015)... May 6, 2015  Cardica, Inc. (Nasdaq: CRDC ... quarter ended March 31, 2015. Cardica,s management will hold ... discuss the financial results and provide an update on ... the third quarter of fiscal 2015, we reintroduced a ... white cartridges only. This controlled commercial release is focusing ...
(Date:5/6/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences company ... products and services, today reported total revenues of $37.8 million ... compared to revenues of $37.1 million for the first quarter ... or $0.12 per share, basic and $0.11 per share, diluted, ... of $15.7 million, or $0.13 per share, basic and diluted, ...
(Date:5/6/2015)... BioPharma Corp. (NASDAQ and MTA: CTIC) today reported financial ... "After reporting positive top-line results ... during the quarter, we have subsequently received positive feedback ... by the potential opportunity for pacritinib to meet a ... with myelofibrosis, specifically in the portion of patients that ...
Breaking Medicine Technology:Cardica Announces Fiscal 2015 Third Quarter Financial Results 2Cardica Announces Fiscal 2015 Third Quarter Financial Results 3Cardica Announces Fiscal 2015 Third Quarter Financial Results 4Cardica Announces Fiscal 2015 Third Quarter Financial Results 5Cardica Announces Fiscal 2015 Third Quarter Financial Results 6Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 2Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 3Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 4Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 5Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 6Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 7Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 8Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 9Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 10Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 11Sequenom, Inc. Reports Financial Results For The First Quarter Of 2015 12CTI BioPharma Reports First Quarter 2015 Financial Results 2CTI BioPharma Reports First Quarter 2015 Financial Results 3CTI BioPharma Reports First Quarter 2015 Financial Results 4CTI BioPharma Reports First Quarter 2015 Financial Results 5CTI BioPharma Reports First Quarter 2015 Financial Results 6CTI BioPharma Reports First Quarter 2015 Financial Results 7CTI BioPharma Reports First Quarter 2015 Financial Results 8CTI BioPharma Reports First Quarter 2015 Financial Results 9
... , SUNNYVALE, Calif., Dec. 16 ... field of radiosurgery, announced today that its president and chief executive ... 28th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, ... A live webcast of each presentation will be available online from ...
... CHICAGO, Dec. 16 A new application developed ... of specialty pharmaceuticals has increased health plan staff productivity and ... a leading diagnostic imaging benefit management and technology company with ... operating subsidiary of WellPoint, Inc. (NYSE: WLP ), ...
Cached Medicine Technology:Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 2American Imaging Management's New Specialty Drug Program Delivers Immediate Results 3American Imaging Management's New Specialty Drug Program Delivers Immediate Results 4
The FLO-GARD 6201 Volumetric Infusion Pump and the FLO-GARD 6301 Dual-Channel Volumetric Infusion Pump are industry standard in standard set infusion pump technology....
... For more than 20 years, AMS ... various healthcare and industrial clients in ... Accuracy, Convenience, Speed, and Economy. Always ... remain focused on the individual needs ...
... the Division of Pathology and Laboratory Medicine ... nation's largest and most comprehensive academic medical ... 700 employees and more than 40 pathologists ... million laboratory test results, interpretations and diagnostic ...
ChildLab is a service of Children's Hospital, Columbus Ohio...
Medicine Products: